ID
25396
Beschreibung
Phase A - Year 2 Extension - Telephone contact 30 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499 Study ID: 100388 Clinical Study ID: 100388 Study Title: Study in Healthy Children (<2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals' Live Attenuated Varicella Vaccine (VarilrixTM) and of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00226499 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Varicella Vaccine Trade Name: BIO OKAH; Varilrix Study Indication: Varicella
Stichworte
Versionen (1)
- 02/09/17 02/09/17 -
Rechteinhaber
glaxoSmithKline
Hochgeladen am
2 settembre 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Phase A - Year 2 Extension - Telephone contact 30 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499
Phase A - Year 2 Extension - Telephone contact 30 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499
Beschreibung
Household exposure
Alias
- UMLS CUI-1
- C0332157
- UMLS CUI-2
- C0020052
Beschreibung
Exposure in household to varicella/zoster
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0008049
- UMLS CUI [1,2]
- C0332157
- UMLS CUI [1,3]
- C0020052
- UMLS CUI [2,1]
- C0740380
- UMLS CUI [2,2]
- C0332157
- UMLS CUI [2,3]
- C0020052
Beschreibung
Household exposure number
Alias
- UMLS CUI-1
- C0332157
- UMLS CUI-2
- C0020052
- UMLS CUI-3
- C0449788
Beschreibung
Household Exposure No
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0332157
- UMLS CUI [1,2]
- C0020052
- UMLS CUI [1,3]
- C0449788
Beschreibung
Date of onset exposure
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0574845
- UMLS CUI [1,2]
- C0332157
Beschreibung
Type of exposure
Datentyp
integer
Alias
- UMLS CUI [1]
- C0332157
Beschreibung
Varicella or zoster
Alias
- UMLS CUI-1
- C0008049
- UMLS CUI-3
- C0740380
Beschreibung
if 'yes', please complete the Varicella or Zoster Case section.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0037088
- UMLS CUI [1,2]
- C0740380
- UMLS CUI [2,1]
- C0037088
- UMLS CUI [2,2]
- C0008049
Beschreibung
Number of episodes of varicella/zoster signs and symptoms
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0037088
- UMLS CUI [1,2]
- C0740380
- UMLS CUI [2,1]
- C0037088
- UMLS CUI [2,2]
- C0008049
Beschreibung
Serious adverse event
Alias
- UMLS CUI-1
- C1519255
Ähnliche Modelle
Phase A - Year 2 Extension - Telephone contact 30 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499
C0681850 (UMLS CUI [1,2])
C0332157 (UMLS CUI [1,2])
C0020052 (UMLS CUI [1,3])
C0740380 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0020052 (UMLS CUI [2,3])
C0020052 (UMLS CUI-2)
C0449788 (UMLS CUI-3)
C0020052 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,3])
C0332157 (UMLS CUI [1,2])
C0740380 (UMLS CUI [1,2])
C0037088 (UMLS CUI [2,1])
C0008049 (UMLS CUI [2,2])
C0740380 (UMLS CUI [1,2])
C0037088 (UMLS CUI [2,1])
C0008049 (UMLS CUI [2,2])
Keine Kommentare